
Unichem Laboratories Limited has informed the Exchange about press release dated 28-Feb-2022 titled ANDA Approval for Divalproex Sodium Extended-Release Tablets USP, 250 mg and 500 mg
Filed with NSE ·

Unichem Laboratories Limited has informed the Exchange about press release dated 28-Feb-2022 titled ANDA Approval for Divalproex Sodium Extended-Release Tablets USP, 250 mg and 500 mg
6ix hasn’t read this filing yet.
Unichem Laboratories Limited on 6ix
Follow Unichem Laboratories into a list and get an email when it puts out news.
Follow Unichem Laboratories